Orchid Pharma Limited (ORCHPHARMA) - Total Liabilities
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has total liabilities worth Rs6.23 Billion INR (≈ $67.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Orchid Pharma Limited net asset momentum to track the company's year-over-year net asset growth rate.
Orchid Pharma Limited - Total Liabilities Trend (2004–2026)
This chart illustrates how Orchid Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Orchid Pharma Limited generate to measure how efficiently the company converts operating cash flow to free cash.
Orchid Pharma Limited Competitors by Total Liabilities
The table below lists competitors of Orchid Pharma Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Electronics Mart India Limited
NSE:EMIL
|
India | Rs21.71 Billion |
|
Ipek Dogal Enerji Kaynaklari Arastirma ve Uretim AS
IS:IPEKE
|
Turkey | TL4.00 Billion |
|
Invesco Municipal Trust
NYSE:VKQ
|
USA | $341.88 Million |
|
SFA Semicon Co. Ltd
KQ:036540
|
Korea | ₩80.69 Billion |
|
Ningbo Sinyuan ZM Technology Co. Ltd. A
SHE:301398
|
China | CN¥862.44 Million |
|
Sharda Motor Industries Limited
NSE:SHARDAMOTR
|
India | Rs7.49 Billion |
|
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
|
China | CN¥2.63 Billion |
|
PIERER Mobility AG
VI:PKTM
|
Austria | €1.44 Billion |
Liability Composition Analysis (2004–2026)
This chart breaks down Orchid Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Orchid Pharma Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orchid Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orchid Pharma Limited (2004–2026)
The table below shows the annual total liabilities of Orchid Pharma Limited from 2004 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs6.23 Billion ≈ $67.39 Million |
+48.14% |
| 2025-03-31 | Rs4.21 Billion ≈ $45.49 Million |
+9.42% |
| 2024-03-31 | Rs3.84 Billion ≈ $41.57 Million |
-28.36% |
| 2023-03-31 | Rs5.37 Billion ≈ $58.03 Million |
+15.84% |
| 2022-03-31 | Rs4.63 Billion ≈ $50.09 Million |
-20.73% |
| 2021-03-31 | Rs5.84 Billion ≈ $63.19 Million |
-15.79% |
| 2020-03-31 | Rs6.94 Billion ≈ $75.04 Million |
-81.65% |
| 2019-03-31 | Rs37.81 Billion ≈ $408.91 Million |
-3.47% |
| 2018-03-31 | Rs39.17 Billion ≈ $423.62 Million |
+5.23% |
| 2017-03-31 | Rs37.22 Billion ≈ $402.56 Million |
-2.38% |
| 2016-03-31 | Rs38.13 Billion ≈ $412.36 Million |
+2.17% |
| 2015-03-31 | Rs37.32 Billion ≈ $403.60 Million |
-12.61% |
| 2013-03-31 | Rs42.70 Billion ≈ $461.83 Million |
+52.35% |
| 2012-03-31 | Rs28.03 Billion ≈ $303.13 Million |
-6.55% |
| 2011-03-31 | Rs29.99 Billion ≈ $324.37 Million |
+5.76% |
| 2010-03-31 | Rs28.36 Billion ≈ $306.69 Million |
-21.23% |
| 2009-03-31 | Rs36.00 Billion ≈ $389.34 Million |
+27.70% |
| 2008-03-31 | Rs28.19 Billion ≈ $304.89 Million |
+17.18% |
| 2007-03-31 | Rs24.06 Billion ≈ $260.19 Million |
+72.72% |
| 2006-03-31 | Rs13.93 Billion ≈ $150.64 Million |
+3.05% |
| 2005-03-31 | Rs13.52 Billion ≈ $146.18 Million |
+32.85% |
| 2004-03-31 | Rs10.17 Billion ≈ $110.03 Million |
-- |
About Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more